Fact CheckerSign in

NCT06490003Recruiting

Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma

Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma by Biopsy Specimens.

Source: ClinicalTrials.gov · Last updated 13 Jul 2026

Brief summary (registry, in English)

Esophageal cancer remains a disease with a poor prognosis. Chemotherapy is an important part of its treatment, but there are cases in which chemotherapy is ineffective. The investigators aim to develop a model to predict the response to chemotherapy by DNA methylation of preoperative biopsy specimens to identify the chemotherapy ineffective group.

Status (registry)
Recruiting
Study type
Observational
Enrollment
150 (estimated)
First submitted
21 Jun 2024
Start date
1 Jun 2004
Primary completion date
18 Jun 2028
Lead sponsor
City of Hope Medical Center
NCT number
NCT06490003

What you commit to

  • Study type: Observational
  • Planned participants: 150
  • From 1 Jun 2004 to the primary completion date, 18 Jun 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients who cannot assess at 2 months later after chemotherapy.

Other illness

  • Patients with multiple cancers.

Other

  • Patients for whom a preoperative biopsy sample cannot be obtained

Who the study is looking for

  • Patients who had histologically confirmed esophageal squamous cell carcinoma.
  • Patients who had undergone chemotherapy.
  • Patients receiving initial chemotherapy
  • Written informed consent following full study information is provided to the patient.

Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Yamanashi Universiy
Coordinator of this site? Confirm its status
ChūōJapanRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.